Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

44.47
-0.1239-0.28%
Volume:10.98K
Turnover:485.37K
Market Cap:215.23M
PE:- -
High:44.71
Open:44.71
Low:43.60
Close:44.59
52wk High:47.00
52wk Low:26.29
Shares:4.84M
Float Shares:4.84M
Volume Ratio:0.74
T/O Rate:0.23%
Dividend:0.02
Dividend Rate:0.04%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Eli Lilly’s New Obesity Drug LY3549492 Moves Forward With Completed Phase 1 Trial

TIPRANKS
·
28 mins ago

Roche, Eli Lilly's Alzheimer's Blood Test Gets FDA Clearance

Reuters
·
Yesterday

Labcorp to offer Elecsys pTau-217 test for Alzheimer’s disease

TIPRANKS
·
Yesterday

Barclays Sticks to Its Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Hanmi Pharmaceutical Shares Jump After Signing $2.31b Licensing Deal with Genentech

Dow Jones
·
Yesterday

Eli Lilly: Working with Nice on Assessment of Foundayo for Potential Use on Nhs in England

THOMSON REUTERS
·
Yesterday

Eli Lilly Launches Oral Weight-Loss Pill Foundayo in UK

Reuters
·
Yesterday

Eli Lilly: Foundayo NOW Available in UK to be Prescribed for Eligible Adults Via Private Prescription

THOMSON REUTERS
·
Yesterday

Eli Lilly: in UK, Foundayo is Priced Lower than Mounjaro; Likely to be in Order of £100 to £120

THOMSON REUTERS
·
Yesterday

美股周五热点:Moderna领涨医疗板块,英伟达与特斯拉重大动态

Deep News
·
Aug 22

Eli Lilly Targets Ramadan Diabetes Market With New Orforglipron Trial

TIPRANKS
·
Aug 22

Eli Lilly’s Dulaglutide Study Sheds Light on Fasting Risks and Diabetes Care

TIPRANKS
·
Aug 22

Pharma Stocks Have Rallied. 2 Stocks to Avoid-and 2 to Buy.

Dow Jones
·
Aug 21

Revolution Medicines, Inc. : Bernstein Raises Target Price to $179 from $151

THOMSON REUTERS
·
Aug 21

Eli Lilly Advances Early-Stage Eloralintide Trial: What Investors Should Watch

TIPRANKS
·
Aug 21

Revolution Medicines Advances RASolve 308 Lung Cancer Trial, Raising Long-Term Upside Potential for RVMD

TIPRANKS
·
Aug 21

Eli Lilly’s Lebrikizumab Trial Completion Signals New Growth Path in Atopic Dermatitis

TIPRANKS
·
Aug 21

Eli Lilly Revenue Jumps 48% as Mounjaro and Zepbound Sales Reach $14.9B

TradingKey
·
Aug 20

Pharma Sector Doubles Down on AI Amid Hopes of Slashing Costs, Timelines

Reuters
·
Aug 20

7 Growth Stocks Holding up in a Tough Market

Dow Jones
·
Aug 20